Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 7.66
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Country Condo's Limited engages in the real estate business in India. It develops and sells residential layouts; and constructs compound walls, etc. The company was formerly known as Neocure Therapeutics Ltd. and changed its name to Country Condo's Limited in December 2006. Country Condo's Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Data is available to registered users only
